問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林理涵
下載
2024-11-01 - 2027-04-30
Condition/Disease
Test Drug
Participate Sites9Sites
Recruiting9Sites
2021-11-03 - 2025-08-25
Participate Sites4Sites
Recruiting4Sites
2024-01-22 - 2027-05-27
Participate Sites12Sites
Not yet recruiting1Sites
Recruiting11Sites
2021-10-01 - 2027-12-31
Participate Sites7Sites
Recruiting7Sites
2024-01-01 - 2030-12-31
Participate Sites17Sites
Recruiting17Sites
2017-02-10 - 2025-12-31
Participate Sites15Sites
Recruiting13Sites
未分科
Division of Hematology & Oncology
2022-03-09 - 2026-12-15
Participate Sites6Sites
Recruiting6Sites
2024-01-15 - 2029-12-31
Participate Sites5Sites
Recruiting5Sites
2020-06-01 - 2027-12-31
2019-09-01 - 2019-08-06
NSCLC
Tislelizumab
Participate Sites8Sites
Recruiting3Sites
Terminated5Sites
全部
